TY  - CHAP
M1  - Book, Section
TI  - Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo
A1  - Widerman, Meagan
A1  - Pratte, Michael
PY  - 2015
T2  - 2 Minute Medicine
AB  - 
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesssurgery.mhmedical.com/updatesContent.aspx?gbosid=569957
ER  -